Outlook Therapeutics, Inc. · NASDAQ:OTLK
Mitchell P. Kopin's stake in Outlook Therapeutics, Inc. fell to 4.99% (Schedule 13G)
Event Apr 22, 2026 · Filed Apr 24, 2026
Mitchell P. Kopin's stake in Outlook Therapeutics, Inc. fell to 4.99%, 5,990,447 shares, as a passive investor on Apr 22, 2026. Filed Apr 24, 2026 (Schedule 13G).
- Stake
- 4.99%
- Shares
- 5,990,447
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Mitchell P. Kopin | 4.99% | 5,990,447 |
| Daniel B. Asher | 4.99% | 5,990,447 |
| Intracoastal Capital LLC | 4.99% | 5,990,447 |
Source
Related
- Outlook Therapeutics, Inc.
- Mitchell P. Kopin
- Outlook Therapeutics, Inc. shareholders
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026